Log in

Relevant bibliographies by topics / Hepatitis C – Psychological aspects / Journal articles

Journal articles on the topic 'Hepatitis C – Psychological aspects'

To see the other types of publications on this topic, follow the link: Hepatitis C – Psychological aspects.

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hepatitis C – Psychological aspects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Афонина, E. Afonina, Смекалкина, and L. Smekalkina. "Current State of the Treatment Problem of Patients With Chronic Hepatitis C (Literature Review)." Journal of New Medical Technologies 22, no. 2 (February 25, 2015): 116–21. http://dx.doi.org/10.12737/11856.

Full text

Abstract:

Contemporary views of experts on integrated healthcare and psychological approach to diagnosis and treatment of patients with chronic hepatitis С are presented in review. Combined mental disorders were found to have a maladaptive effect on patients to determine the severity of clinical status when standard treatment was used in patients. The use of interferons, common in this disease, provokes more than half of the patients the psychiatric symptoms, especially depressive. Psychosomatic and somatopsychic maladaptive interactions have an impact on patients, cause some problems and lead often to disability of people of working age. In practice, the doctor of the infectious department pays little attention to psychological aspects of care management of such patients. The researchers are now actively seeking the optimal combination of standard antiviral therapy and modern methods of psychological correction taking into account comorbid mental maladjustment. Long-term pharmacotherapy with the use of traditional psychotropic drugs is an additional unwanted burden on the liver. Timely diagnosis and correction of concomitant mental disorders in the patients with hepatitis С in somatic hospitals by complementary non-pharmacological methods, is a very urgent task.

APA, Harvard, Vancouver, ISO, and other styles

2

Reimer, Jens, Markus Backmund, and Christian Haasen. "New psychiatric and psychological aspects of diagnosis and treatment of hepatitis C and relevance for opiate dependence." Current Opinion in Psychiatry 18, no. 6 (November 2005): 678–83. http://dx.doi.org/10.1097/01.yco.0000186812.01202.a5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pourmarzi, Davoud, Andrew Smirnov, Lisa Hall, Gerard FitzGerald, and Tony Rahman. "‘I’m over the moon!’: patient-perceived outcomes of hepatitis C treatment." Australian Journal of Primary Health 26, no. 4 (2020): 319. http://dx.doi.org/10.1071/py20013.

Full text

Abstract:

Understanding patient-perceived outcomes is crucial for assessing the effectiveness and acceptability of hepatitis C virus (HCV) treatment. This study aimed to explore patient-perceived outcomes of receiving direct-acting antivirals (DAAs). This study was a part of a mixed-methods case study of the Prince Charles Hospital program for improving access to HCV treatment in community settings. Data were collected using semi-structured interviews with nine patients who were in different stages of their treatment for HCV. The participants were recruited using purposive sampling. All interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis. Patients emphasised ‘having more energy’ when reporting improvements in their physical health following treatment. They also reported a newly developed sense of freedom and hope. Improved physical and mental health empowered them to start a healthy lifestyle and to practise self-protection from the risk of re-infection. Patients highlighted their desire to help other patients to receive treatment, which was connected to their experience of the services that they received and their perceived health outcomes. Patients expect and experience various outcomes that are related to the physical, psychological and social aspects of living with, and being cured of HCV. Emphasis on the short-term outcomes of receiving HCV treatment may improve HCV treatment uptake and adherence rates.

APA, Harvard, Vancouver, ISO, and other styles

4

Mezzaroma, Ivano, Gianpiero D'Offizi, Elena Pinter, Rosetta Ferrara, Rosamaria Rosso, Emma Guerra, Giovanni Ricci, Maria Carta, Silvia Angelini, and Fernando Aiuti. "Immunological, Clinical and Epidemiological Aspects of an HIV-1 Positive Drug Abuser Cohort." Journal of Drug Issues 24, no. 4 (October 1994): 657–72. http://dx.doi.org/10.1177/002204269402400407.

Full text

Abstract:

We analyzed a cohort of intravenous drug abusers with HIV-1 disease attending our institute in the years 1985–1993. We focused particular attention on the epidemiological analysis of patients, and their clinical, immunological and infectious conditions. The significance of biological markers, particulary CD4+ lymphocyte count and the occurence of other viral infections such as Cytomegalovirus, Epstein-Barr virus, Herpes Simplex virus and Hepatitis B and C viruses in the progress of HIV-1 disease were evaluated. At least two-thirds of the patients at different stages of HIV-1 were treated with antiretroviral drugs: zidovudine (AZT) from 1987 up to the present and more recently didanosine (DDI) alone or in combination with AZT. Psychological and behavioral aspects of our HIV-1 infected drug abusers, in particular needle exchange and condom use, were analyzed.

APA, Harvard, Vancouver, ISO, and other styles

5

MAIN, J. "Hepatitis C: Clinical aspects." Journal of Infection 30, no. 2 (March 1995): 103–6. http://dx.doi.org/10.1016/s0163-4453(95)80003-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Eshelman, A. K., T. L. Belville-Robertson, and L. R. Clemensen. "PSYCHOLOGICAL ISSUES IN HEPATITIS C." Psychosomatic Medicine 61, no. 1 (1999): 87. http://dx.doi.org/10.1097/00006842-199901000-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

GILL, MUZAFFAR L., MUSLIM ATIQ, SYMA SATTAR, and NASIR KHOKHAR. "Psychological implications of hepatitis C virus diagnosis." Journal of Gastroenterology and Hepatology 20, no. 11 (November 2005): 1741–44. http://dx.doi.org/10.1111/j.1440-1746.2005.04061.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Diament, Decio. "Epidemiological aspects of hepatitis C in Brazil." Brazilian Journal of Infectious Diseases 11 (October 2007): 6–7. http://dx.doi.org/10.1590/s1413-86702007000700002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Barone, Antonio Alci. "Hepatitis C: virological aspects and practical implications." Brazilian Journal of Infectious Diseases 11 (October 2007): 12–13. http://dx.doi.org/10.1590/s1413-86702007000700005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

McCashland, Timothy M. "Retransplantation for recurrent hepatitis C: Positive aspects." Liver Transplantation 9, no. 11 (November 2003): S67—S72. http://dx.doi.org/10.1053/jlts.2003.50249.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Marinho, Rui T., Miguel C. Moura, Jose A. Giria, and Paulo Ferrinho. "EPIDEMIOLOGICAL ASPECTS OF HEPATITIS C IN PORTUGAL." Journal of Gastroenterology and Hepatology 16, no. 9 (September 2001): 1076–77. http://dx.doi.org/10.1046/j.1440-1746.2001.2574a.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kashyap, A. S. "Clinical Aspects of Chronic Hepatitis C Infection." JAMA: The Journal of the American Medical Association 290, no. 11 (September 17, 2003): 1452—b—1452. http://dx.doi.org/10.1001/jama.290.11.1452-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Schattner, A. "Clinical Aspects of Chronic Hepatitis C Infection." JAMA: The Journal of the American Medical Association 290, no. 11 (September 17, 2003): 1453. http://dx.doi.org/10.1001/jama.290.11.1453-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Leblebicioglu, H. "Clinical Aspects of Chronic Hepatitis C Infection." JAMA: The Journal of the American Medical Association 290, no. 11 (September 17, 2003): 1453—a—1453. http://dx.doi.org/10.1001/jama.290.11.1453-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

MCDONALD, JENNIFER, ROHAN JAYASURIYA, PATRICIA BINDLEY, CRAIG GONSALVEZ, and SONJA GLUSESKA. "Fatigue and psychological disorders in chronic hepatitis C." Journal of Gastroenterology and Hepatology 17, no. 2 (February 2002): 171–76. http://dx.doi.org/10.1046/j.1440-1746.2002.02669.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Batchelder, A. W., D. Peyser, S. Nahvi, J. H. Arnsten, and A. H. Litwin. "“Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment." Drug and Alcohol Dependence 153 (August 2015): 66–71. http://dx.doi.org/10.1016/j.drugalcdep.2015.06.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Drochioi, Ana Simona, Evelina Moraru, Bogdan Diaconu, and Dan Cristian Moraru. "Hematological aspects in viral hepatitis C in children." Romanian Medical Journal 65, no. 3 (September 30, 2018): 196–201. http://dx.doi.org/10.37897/rmj.2018.3.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bocec, Ana Simona, Alice Azoicăi, and Evelina Moraru. "Immunological aspects in viral hepatitis C in children." Pediatru.ro 1, no. 53 (2019): 20. http://dx.doi.org/10.26416/pedi.53.1.2019.2347.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Artemova, M. G., and D. T. Abdurakhmanov. "Cryoglobulinemic vasculitis in chronic hepatitis C: Genetic aspects." Terapevticheskii arkhiv 89, no. 4 (April 15, 2017): 110–14. http://dx.doi.org/10.17116/terarkh2017894110-114.

Full text

Abstract:

Cryoglobulinemia (CG) is detected in more than 50% of patients with chronic hepatitis C (CHC); however, only 15—25% of them develop cryoglobulinemic vasculitis (CV) that is a systemic vasculitis due to the formation of immune deposits, which affects small (less than medium-sized) vessels and which is frequently fatal for the patient. The causes of CG only in some patients with CHC and the pathogenesis of CV remain unstudied; however, the accumulated data allow one to identify the special contribution of the patient’s genetic factors to the development of the disease. The paper considers the genetic aspects of the development of CG and CV in CHC.

APA, Harvard, Vancouver, ISO, and other styles

20

Anne Marie, COUROUCE, and BUSCH Michael. "Symposium S01 Hepatitis B and C - Biological aspects." Transfusion Clinique et Biologique 8 (June 2001): 7–8. http://dx.doi.org/10.1016/s1246-7820(01)00143-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Hosseini Moghaddam, Seyed Mohammadmehdi, Seyed Moayed Alavian, and Mohammad Rahnavardi. "Therapeutic Aspects of Hepatitis C in Hemodialysis Patients." American Journal of Nephrology 29, no. 2 (2009): 123–28. http://dx.doi.org/10.1159/000151633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Flamm, S. L. "Clinical Aspects of Chronic Hepatitis C Infection--Reply." JAMA: The Journal of the American Medical Association 290, no. 11 (September 17, 2003): 1453—b—1454. http://dx.doi.org/10.1001/jama.290.11.1453-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Atta, M. L. B. Sousa, P. E. Margarida, B. C. Leite, C. M. Pereira, R. Paran??, and A. M. Atta. "Autoimmune Aspects of Hepatitis C in Bahia (Brazil)." JCR: Journal of Clinical Rheumatology 12, Supplement (April 2006): S6. http://dx.doi.org/10.1097/01.rhu.0000217148.53598.0c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Sumlivaia, O. N., M. S. Nevzorova, A. T. Sayfitova, and S. A. Vysotin. "Modern clinical laboratory aspects of chronic hepatitis C." Experimental and Clinical Gastroenterology, no. 7 (September 27, 2021): 37–42. http://dx.doi.org/10.31146/1682-8658-ecg-191-7-37-42.

Full text

Abstract:

Aim. Assess the current diagnostic value of clinical laboratory markers of liver damage in chronic viral hepatitis C. Materials and methods. Comprehensive clinical examination of 194 patients with the diagnosis chronic hepatitis C and 73 almost healthy faces was conducted. Results. According to the clinical examination, 91% of patients have hepatomegaly. According to the results of elastography, the subgroup without fibrosis F0 49 (25%) people, with fibrosis of stages F1-F3-145 (75%) patients. The occurrence of HCV genotypes was: HCV-1-33%, HCV-2-12% and HCV-3-55%. The virusemia indicator showed large variations of values. During the research it was established that indirect indicators of a fibrosis of a liver: levels of AST and ALT, GGTP, a direct and general bilirubin, the APRI index are authentically exceeded by indexes of control group while the level of thrombocytes and de Ritis’s coefficient authentically decrease. Conclusions. The current course of chronic hepatitis C occurs with hepatomegalia, often associated with gastrointestinal and cardiovascular damage. The most common virus among patients is the HVC-3 genotype virus. When examining indirect markers of fibrosis in viral hepatitis C, the APRI test is an early predictor and has high predictive value. Platelet levels decrease with viral liver damage. As a consequence, the APRI index increases and the de Ritis ratio decreases.

APA, Harvard, Vancouver, ISO, and other styles

25

Katz, D. "Psychological Aspects of Gifts From Drug Companies." JAMA: The Journal of the American Medical Association 290, no. 18 (November 12, 2003): 2404—b—2405. http://dx.doi.org/10.1001/jama.290.18.2404-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Tansey, M. "Psychological Aspects of Gifts From Drug Companies." JAMA: The Journal of the American Medical Association 290, no. 18 (November 12, 2003): 2405—b—2406. http://dx.doi.org/10.1001/jama.290.18.2405-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Dana, J. "Psychological Aspects of Gifts From Drug Companies--Reply." JAMA: The Journal of the American Medical Association 290, no. 18 (November 12, 2003): 2406—b—2407. http://dx.doi.org/10.1001/jama.290.18.2406-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Ferreira, M. J., R. Margalho, C. Fernandes, J. Serra, J. Cunha, and M. Silvestre. "Depression and Hepatitis C." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70874-0.

Full text

Abstract:

Combination therapy of peginterferon and ribavirin for HCV has been recommended as a first choice for chronic hepatitis C. INF therapy has been associated with various IFN-related adverse events, such as psychological disturbances. Beyond that preexisting mental disorders are considered risk factors for INF-alfa-induced severe psychiatric side effects such as depression and/or suicidality, consequently many of these patients remain untreated even tough they fulfil the medical criteria for antiviral treatment of chronic hepatitis C.The authors relate the case of a patient, 56 year's old, sent to infecciology consultation because she had alterations in abnormal liver function tests. She had a previous history of mental disorder with neurotic personality traits and she was treated with psychiatric medication.She had treatment for chronic hepatitis C with peginterferon and ribavirin as well psychiatric and psychotherapeutic support.A low sustained virologic response was obtained however the depressive picture has been difficult to handle so she had had already had a psychiatric hospitalization. There were several adverse life events that can not be forgotten as they certainly trigger and exacerbate the depressive symptomatology.We assume that psychiatric patients have more depressive symptoms before and during treatment compared with patients without no psychiatric history. This shows that this patients have an increase need for treatment with antidepressants and that a close cooperation with a psychiatrist is always needed.

APA, Harvard, Vancouver, ISO, and other styles

29

Withers, NW, RC Hilsabeck, P. Malek-Ahmadi, and DA Hensley. "Psychosomatic aspects in liver disease I: chronic hepatitis C." Journal of Psychosomatic Research 55, no. 2 (August 2003): 120–21. http://dx.doi.org/10.1016/s0022-3999(03)00440-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Irshad, M., I. Khushboo, Shiwani Singh, and Sukhbir Singh. "Hepatitis C Virus (HCV): A Review of Immunological Aspects." International Reviews of Immunology 27, no. 6 (January 2008): 497–517. http://dx.doi.org/10.1080/08830180802432178.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Roberts. "The economic aspects of hepatitis C - implications for haemophilia." Haemophilia 5, no. 6 (November 1999): 402–9. http://dx.doi.org/10.1046/j.1365-2516.1999.00363.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Manos, M. Michele, Chanda K. Ho, Rosemary C. Murphy, and Valentina A. Shvachko. "Physical, Social, and Psychological Consequences of Treatment for Hepatitis C." Patient - Patient-Centered Outcomes Research 6, no. 1 (February 19, 2013): 23–34. http://dx.doi.org/10.1007/s40271-013-0005-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Khurshid, Muhammad Adil, Manzoor Ahmad Naeem, and Sohail Hassan. "HEPATITIS C VIRUS (HCV)." Professional Medical Journal 25, no. 04 (April 10, 2018): 489–91. http://dx.doi.org/10.29309/tpmj/2018.25.04.333.

Full text

Abstract:

Objectives: This study was carried out to find out the frequency of Hepatitis CVirus (HCV) infection in patients with end stage renal disease requiring Haemodialysis and theirrate of seroconversion to HCV positive during Haemodialysis in special subgroup population,the labour class of Punjab Pakistan. Study Designs: Cross-sectional descriptive study. Place &Duration: Haemodialysis Unit Nawaz Sharif Social Security Hospital, Multan Road Lahore fromJanuary 2009 through December 2012. Material and Method: A total of 92 patients, aged 15to 70 years belonging to Labour class of the Punjab were included in the study, who reportedfor Haemodialysis in our unit. All the patients were tested for the presence of HCV antibodyby rapid immunochromatographic technique (ICU devices) and also confirmed with EnzymeLinked Immunosorbant Assay (ELIZA) at the start of Haemodialysis and thereafter quarterly fortheir conversion to HCV positive state. Results: Out of 92 patients 34 (39.96%) were positivefor HCV Antibody 3 patients (3.26%) were positive for HbsAg where as 55 patients (59.78%)were negative for HbsAg or HCV Antibody. Out of 55 patients negative for HCV, 12 patientswere converted to HCV positive state within 18 months of Haemodialysis. Conclusion: A highincidence of HCV positive, 36.96 % was noted with a high seroconversion rate of 21.82 %toHCV positive. This study supports the idea that better socioeconomic status and awareness ofpreventive health aspects remains the corner stone for prevention and spread of HCV infection.

APA, Harvard, Vancouver, ISO, and other styles

34

Dobbs, F. "Psychological aspects of lower urinary tract infections in women." BMJ 304, no. 6823 (February 8, 1992): 384–85. http://dx.doi.org/10.1136/bmj.304.6823.384-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Sinclair, Michael, Susan McPherson, Robert Bor, and Lisa Orban. "Another dragon in the kitchen: Psychological experiences of hepatitis C treatment among HIV-hepatitis C co-infected gay men." Counselling and Psychotherapy Research 11, no. 3 (September 2011): 228–36. http://dx.doi.org/10.1080/14733145.2010.498584.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Berezenko, V. S., and O. V. Tsaryova. "Clinical and paraclinical aspects of chronic hepatitis C in children." PERINATOLOGIYA I PEDIATRIYA, no. 2(62) (July 15, 2015): 38–42. http://dx.doi.org/10.15574/pp.2015.62.38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kajdaniuk, D., B. Marek, E. Janczewska-Kazek, D. Niedziolka, B. Kos-Kudla, Z. Ostrowska, and H. Borgiel-Marek. "Osteodystrophy in patients with chronic viral hepatitis C — pathogenetic aspects." Journal of Hepatology 38 (April 2003): 148. http://dx.doi.org/10.1016/s0168-8278(03)80775-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Issaeva, N. "Hepatitis B and C: seroepidemiological aspects and modern prevention approach." Journal of Hepatology 34 (April 2001): 178. http://dx.doi.org/10.1016/s0168-8278(01)80653-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Issaeva, N., A. Skovorodin, and O. Kanin. "Hepatitis B and C: seroepidemiological aspects and modern prevention approach." Journal of Hepatology 34 (April 2001): 178. http://dx.doi.org/10.1016/s0168-8278(01)81528-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Roche, Bruno, and Didier Samuel. "Aspects of hepatitis C virus infection relating to liver transplantation." European Journal of Gastroenterology & Hepatology 18, no. 4 (April 2006): 313–20. http://dx.doi.org/10.1097/00042737-200604000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Rehermann, Barbara, and Michael P. Manns. "Immunologic aspects of acute and chronic hepatitis B and C." Current Opinion in Gastroenterology 12, no. 6 (November 1996): 554–59. http://dx.doi.org/10.1097/00001574-199611000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Hilsabeck, Robin C., Steven A. Castellon, and Charles H. Hinkin. "Neuropsychological Aspects of Coinfection with HIV and Hepatitis C Virus." Clinical Infectious Diseases 41, Supplement_1 (July 1, 2005): S38—S44. http://dx.doi.org/10.1086/429494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Chew, Kara W., and Debika Bhattacharya. "Virologic and immunologic aspects of HIV–hepatitis C virus coinfection." AIDS 30, no. 16 (October 2016): 2395–404. http://dx.doi.org/10.1097/qad.0000000000001203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Bobinski, Mary Anne. "Health Care–Associated Hepatitis B and C Viruses: Legal Aspects." Clinics in Liver Disease 14, no. 1 (February 2010): 105–17. http://dx.doi.org/10.1016/j.cld.2009.11.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rehermann, Barbara, and Antonio Bertoletti. "Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections." Hepatology 61, no. 2 (January 20, 2015): 712–21. http://dx.doi.org/10.1002/hep.27323.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Jonas, Maureen M. "Hepatitis C virus infection: clinical aspects and treatment with interferon alfa." Clinical Therapeutics 18 (January 1996): 110–25. http://dx.doi.org/10.1016/s0149-2918(96)80203-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Chutaputti, Anuchit. "Adverse effects and other safety aspects of the hepatitis C antivirals." Journal of Gastroenterology and Hepatology 15, no. 5 (Suppl.) (May 2000): E156—E163. http://dx.doi.org/10.1046/j.1440-1746.2000.02114.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Groma, V., V. Zalcmane, S. Skuja, and J. Keiss. "514 ULTRASTRUCTURAL ASPECTS OF LIVER REGENERATION IN CHRONIC HEPATITIS C PATIENTS." Journal of Hepatology 48 (January 2008): S194. http://dx.doi.org/10.1016/s0168-8278(08)60516-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Galova, E. A. "Age aspects of the incidence of chronic hepatitis C in children." Medical Almanac, no. 3-4 (October 14, 2019): 11–17. http://dx.doi.org/10.21145/2499-9954-2019-3-11-17.

Full text

Abstract:

Purpose of the study: to reveal characteristics of chronic viral hepatitis C (HCV) incidence in babies and preschoolers, schoolchildren, teenagers on the example of the Nizhny Novgorod region. Materials and methods. The article presents official epidemiological information on the incidence of HCV in children in the Nizhny Novgorod region in 1995–2015. Data statistical processing was performed with Statistica 7.0. soft ware package. Zero hypotheses were rejected at significance level of the corresponding statistical criterion p < 0,05. Results. The study revealed differences of HCV-epidemic process in infants and preschoolers, schoolchildren and teenagers. The incidence of HCV in children 0–6 years old and 15–17 years old is characterized by a lack of reduction and an uncertain prognosis (p < 0,05); the positive prognosis is possible in schoolchildren aged 7–14 years (p < 0,05). There was an increase of patients of younger age groups in the proportion, and decrease of cases frequency in children 7–14-year-olds. The authors identified that the viral hepatitis C incidence is correlate with the public health indicators and with the health care institutions activities; the correlations strength and correlations pattern is depend on age. The article presents a quantitative assessment of the relationship between the children HCV incidence in different age periods and the public health indicators and activities health institutions. Conclusions. In HCV-epidemic process in children at the present there is a redistribution of older and younger age groups role in its maintenance with the leading significance of the latter. Obtained results prove the significant contribution of HCV positive women of fertile age in the HCV- epidemic process in children at the present stage.

APA, Harvard, Vancouver, ISO, and other styles

50

Weiss, Jeffrey J., and Jack M. Gorman. "Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV." Current HIV/AIDS Reports 3, no. 4 (December 2006): 176–81. http://dx.doi.org/10.1007/s11904-006-0013-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!